查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571655

眼科黏性手术器械市场规模、份额和趋势分析报告：按类型、来源、应用、地区、细分市场预测，2024-2030年

Ophthalmic Viscosurgical Devices Market Size, Share & Trends Analysis Report By Type (Dispersive, Cohesive Viscoadaptive), By Source (Animal, Biological & Semi-synthetic), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

眼科黏性手术器械市场成长与趋势：

根据Grand View Research, Inc.的最新报告，到2030年，全球眼科黏稠手术器械市场规模将达到6.395亿美元，2024年至2030年的复合年增长率预计将达到6.3%。

老年人口的稳定成长和眼科疾病的高盛行率预计将推动成长。眼科医疗设施的不断发展预计将在不久的将来增加对眼科黏性手术设备（OVD）的需求。

糖尿病盛行率的增加预计将成为推动市场成长的主要因素。 1 型和第 2 型糖尿病患者在某些时候更有可能患有白内障。目前，白内障的唯一治疗方法是手术，因此对白内障手术必需的眼科黏弹剂的需求正在增加。此外，印度、日本、美国和西欧国家等国家的白内障手术率（CSR）也不断增加，导致全球白内障负担增加。

积极的政府和非政府倡议，如眼科检查计划、州和国家眼保健系统、眼科培训和教育计划，预计将在眼科黏性手术设备市场的成长中发挥重要作用。例如，世界糖尿病基金会为欠发达经济体的初级保健眼科 HCP 开展培训和发展计划，以提高白内障治疗方法的传播和认识。

适用于常规和复杂眼科手术各个阶段的超黏性和黏性OVD等先进黏弹性材料新兴市场的开拓是一种新兴趋势。例如，黏性 OVD 将黏性 OVD 和分散 OVD 结合在一个注射器中，使其适用于复杂的白内障手术和眼外伤病例。

眼科黏性手术器械市场报告亮点：

  • 按类型划分，内聚式 OVD 和分散式 OVD 共同占据了很大的市场份额，因为它们同时用于眼科手术。由于复杂眼科手术的增加，使用黏性 OVD 改善了手术结果等因素，黏性 OVD 预计在预测期内也将实现健康的复合年增长率。
  • 从应用来看，白内障手术领域在 2023 年占据最大的市场占有率，预计在预测期内将显着成长。糖尿病盛行率上升、老年人口增加以及有利的眼保健政策是预计推动成长的一些因素。 OVD 在青光眼和玻璃体切除手术等眼科手术中的广泛应用预计将出现成长并推动市场成长。
  • 2023年，北美占据眼科黏稠手术器械市场的最大份额。由于眼保健设施的改善和大量患者群的存在，预计亚太地区在预测期内将以最快的复合年增长率增长。
  • 预计来自合成原料的黏弹性体在预测期内将呈现良好的成长率。这是由于与动物黏弹性材料相比，精製成本更低、产量更高且萃取过程更容易。一个新的趋势是透过基因工程宿主细菌来生产含有低水平内毒素的黏弹剂来提高纯度。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章眼科黏性手术器械市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 眼科 Visco 手术器械市场分析工具
    • 波特的分析
    • PESTEL分析

第四章眼科黏性手术器械市场：类型估计与趋势分析

  • 细分仪表板
  • 眼科 Visco 手术器械市场：2023 年和 2030 年类型变化分析
  • 去中心化
  • 凝聚力
  • 黏度自适应型

第五章眼科黏性手术器械市场：来源估计与趋势分析

  • 细分仪表板
  • 眼科黏性手术器械市场：来源变化分析，2023-2030
  • 动物
  • 生物
  • 半合成

第六章眼科黏性手术器械市场：应用估算与趋势分析

  • 细分仪表板
  • 眼科黏性手术器械市场：2023 年和 2030 年应用变化分析
  • 白内障手术
  • 青光眼手术
  • 角膜移植
  • 玻璃体视网膜移植

第七章眼科黏性手术器械市场：区域估计与趋势分析

  • 2023 年和 2030 年眼科 Visco 手术器械按地区市场占有率（百万美元）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Bausch + Lomb
    • Carl Zeiss Meditec AG
    • Johnson & Johnson Services, Inc.
    • Alcon
    • Rayner Group
    • Bohus BioTech AB
    • BVI
    • Nordic Pharma, Inc.
    • Truviz Ophthalmic
简介目录
Product Code: GVR-3-68038-887-9

Ophthalmic Viscosurgical Devices Market Growth & Trends:

The global ophthalmic viscosurgical devices market size is anticipated to reach USD 639.5 million by 2030, registering a CAGR of 6.3% from 2024 to 2030, according to a new report published by Grand View Research, Inc. Steady rise in geriatric population coupled with high prevalence of ocular disorders is expected to drive the growth. Constantly developing ophthalmic care facilities are expected to contribute to the demand for Ophthalmic Viscosurgical Devices (OVDs) in near future.

Increasing prevalence of diabetes is expected to be a major factor boosting the market growth. Patients with both type 1 and type 2 diabetes are prone to develop cataract at some point in time. Currently, the surgical procedure is the only treatment option for cataract, thereby driving the demand for ophthalmic viscosurgical devices-an integral part of the cataract surgery. Furthermore, the global burden of cataract can be subjected to the increasing Cataract Surgical Rate (CSR) in countries, such as India, Japan, U.S., and several Western European countries.

Favorable government and non-government initiatives, such as ophthalmic screening programs, state and national eye care schemes, ophthalmic training, and education programs are expected to play a significant role in the ophthalmic viscosurgical devices market growth. For instance, the World Diabetes Foundation conducts training and development programs for ophthalmic HCP at primary care in regions of underdeveloped economies, improving the reach and awareness of cataract treatment procedures.

Developing advanced viscoelastics such as super-cohesive and viscoadpative OVD suitable for each stages of routine and complex ocular surgery is an emerging trend in the market. For instance, the viscoadpative OVDs have the combined benefit of cohesive and dispersive OVDs contained in a single syringe suitable for complex cataract surgery and ocular trauma cases.

Ophthalmic Viscosurgical Devices Market Report Highlights:

  • Based on the type, as cohesive and dispersive OVDs are used concomitantly in ocular surgical procedures they together held significant share in the market. In addition, the viscoadaptive OVDs segment is expected to register a healthy CAGR over the forecast period, attributed to factors such as improved surgical outcomes on usage of viscoadpative OVD coupled with increasing number of complex ocular procedures.
  • Based on application, the cataract surgery segment held the largest market share in 2023 and is expected to grow at a significant rate over the forecast period. Rising prevalence of diabetes, expanding geriatric population, favorable eye care policies are some of the factors expected to fuel the growth. Expanding OVDs application into ocular surgeries such as glaucoma and vitrectomy surgery are expected to witness growth, driving the market growth.
  • North America held the largest ophthalmic viscosurgical devices market share in 2023. Asia pacific is expected to expand at a speediest CAGR over the forecast period due to the improving access to ophthalmic care facilities and presence of large patient pool.
  • Viscoelastics derived from synthetic sources is expected to grow at a lucrative rate over the forecast period. This can be attributed to its low purification cost, high percentage of yield and easy extraction process compared to viscoelastic from animal source. The emerging trend is genetically engineering host bacteria to produce viscoelastic with low level of endotoxins thereby enhanced purity.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Ophthalmic Viscosurgical Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Ophthalmic Viscosurgical Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Ophthalmic Viscosurgical Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Ophthalmic Viscosurgical Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Dispersive
    • 4.3.1. Dispersive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cohesive
    • 4.4.1. Cohesive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Viscoadaptive
    • 4.5.1. Viscoadaptive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Viscosurgical Devices Market: Source Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Ophthalmic Viscosurgical Devices Market: Source Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Animal
    • 5.3.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Biological
    • 5.4.1. Biological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Semi-synthetic
    • 5.5.1. Semi-synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Viscosurgical Devices Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Ophthalmic Viscosurgical Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Cataract Surgery
    • 6.3.1. Cataract Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Glaucoma Surgery
    • 6.4.1. Glaucoma Surgery Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Corneal Grafting
    • 6.5.1. Corneal Grafting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Vitreoretinal Grafting
    • 6.6.1. Vitreoretinal Grafting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Viscosurgical Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Ophthalmic Viscosurgical Devices Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Bausch + Lomb
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Carl Zeiss Meditec AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Johnson & Johnson Services, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Alcon
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Rayner Group
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bohus BioTech AB
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. BVI
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Nordic Pharma, Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Truviz Ophthalmic
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives